Proton pump inhibitors inhibit PHOSPHO 1 activity and matrix mineralisation in vitro 1

[1]  Kyungdo Han,et al.  Comparing proton pump inhibitors with histamin-2 receptor blockers regarding the risk of osteoporotic fractures: a nested case-control study of more than 350,000 Korean patients with GERD and peptic ulcer disease , 2020, BMC Geriatrics.

[2]  J. Millán,et al.  How To Build a Bone: PHOSPHO1, Biomineralization, and Beyond , 2019, JBMR plus.

[3]  D. Graham,et al.  Interchangeable Use of Proton Pump Inhibitors Based on Relative Potency , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[4]  B. Fadeel,et al.  Skeletal Mineralization Deficits and Impaired Biogenesis and Function of Chondrocyte‐Derived Matrix Vesicles in Phospho1–/– and Phospho1/Pit1 Double‐Knockout Mice , 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  C. Farquharson,et al.  Characterisation of matrix vesicles in skeletal and soft tissue mineralisation. , 2016, Bone.

[6]  J. Millán,et al.  Phospho1 deficiency transiently modifies bone architecture yet produces consistent modification in osteocyte differentiation and vascular porosity with ageing , 2015, Bone.

[7]  C. Farquharson,et al.  The functional co-operativity of tissue-nonspecific alkaline phosphatase (TNAP) and PHOSPHO1 during initiation of skeletal mineralization. , 2015, Biochemistry and biophysics reports.

[8]  M. H. Fernandes,et al.  Dose‐dependent inhibitory effects of proton pump inhibitors on human osteoclastic and osteoblastic cell activity , 2013, The FEBS journal.

[9]  M. McKee,et al.  Compounded PHOSPHO1/ALPL Deficiencies Reduce Dentin Mineralization , 2013, Journal of dental research.

[10]  J. Millán.  The Role of Phosphatases in the Initiation of Skeletal Mineralization , 2012, Calcified Tissue International.

[11]  M. McKee,et al.  Loss of Skeletal Mineralization by the Simultaneous Ablation of PHOSPHO1 and Alkaline Phosphatase Function: A Unified Model of the Mechanisms of Initiation of Skeletal Calcification , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[12]  G. Sachs,et al.  Novel Approaches to Inhibition of Gastric Acid Secretion , 2010, Current gastroenterology reports.

[13]  E. Duncan,et al.  Marked increase in proton pump inhibitors use in Australia , 2010, Pharmacoepidemiology and drug safety.

[14]  M. Lindstrom,et al.  Do Proton Pump Inhibitors Decrease Calcium Absorption? , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[15]  J. Millán,et al.  Inhibition of PHOSPHO1 activity results in impaired skeletal mineralization during limb development of the chick. , 2010, Bone.

[16]  R. Buchet,et al.  Lansoprazole is an uncompetitive inhibitor of tissue-nonspecific alkaline phosphatase. , 2009, Acta biochimica Polonica.

[17]  C. Cooper,et al.  Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates , 2009, Osteoporosis International.

[18]  D. Bauer,et al.  Acid-Suppressive Medications and Risk of Bone Loss and Fracture in Older Adults , 2008, Calcified Tissue International.

[19]  L. Lix,et al.  Use of proton pump inhibitors and risk of osteoporosis-related fractures , 2008, Canadian Medical Association Journal.

[20]  B. Clarke.  Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture , 2008 .

[21]  U. Fuhr,et al.  Relative potency of proton-pump inhibitors—comparison of effects on intragastric pH , 2008, European Journal of Clinical Pharmacology.

[22]  J. Millán,et al.  Functional Involvement of PHOSPHO1 in Matrix Vesicle–Mediated Skeletal Mineralization , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[23]  C. Farquharson,et al.  The presence of PHOSPHO1 in matrix vesicles and its developmental expression prior to skeletal mineralization. , 2006, Bone.

[24]  P. Vestergaard,et al.  Proton Pump Inhibitors, Histamine H2 Receptor Antagonists, and Other Antacid Medications and the Risk of Fracture , 2006, Calcified Tissue International.

[25]  A. Murray,et al.  Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial. , 2005, The American journal of medicine.

[26]  K. Abe,et al.  Effect of omeprazole, an inhibitor of H+, K+-ATPase, on bone resorption in humans , 1993, Calcified Tissue International.

[27]  C. Farquharson,et al.  PHOSPHO1-A novel phosphatase specifically expressed at sites of mineralisation in bone and cartilage. , 2004, Bone.

[28]  H. Anderson,et al.  Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice. , 2004, The American journal of pathology.

[29]  C. Farquharson,et al.  Comparative modelling of human PHOSPHO1 reveals a new group of phosphatases within the haloacid dehalogenase superfamily. , 2003, Protein engineering.

[30]  H. Anderson.  Matrix vesicles and calcification , 2003, Current rheumatology reports.

[31]  D. Chen,et al.  Long-term omeprazole treatment suppresses body weight gain and bone mineralization in young male rats. , 2001, Scandinavian journal of gastroenterology.

[32]  J. Achard,et al.  Inhibition of gastric secretion by omeprazole and efficiency of calcium carbonate on the control of hyperphosphatemia in patients on chronic hemodialysis. , 1998, Artificial organs.

[33]  R. Håkanson,et al.  Chicken Parathyroid Hormone Gene Expression in Response to Gastrin, Omeprazole, Ergocalciferol, and Restricted Food Intake , 1997, Calcified Tissue International.

[34]  R. Hunt,et al.  Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. , 1997, Gastroenterology.

[35]  R. Wood,et al.  Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans. , 1995, Journal of the American College of Nutrition.

[36]  H. Hsu.  Further studies on ATP-mediated Ca deposition by isolated matrix vesicles. , 1992, Bone and mineral.

[37]  J. Meyer,et al.  Can biological calcification occur in the presence of pyrophosphate? , 1984, Archives of biochemistry and biophysics.

[38]  H. Anderson,et al.  Pyrophosphate stimulation of calcium uptake into cultured embryonic bones. Fine structure of matrix vesicles and their role in calcification. , 1973, Developmental biology.

[39]  R. Robison,et al.  The Possible Significance of Hexosephosphoric Esters in Ossification. Part IV. The Phosphoric Esters of the Blood: Preliminary Communication. , 1924, The Biochemical journal.

[40]  R. Robison.  The Possible Significance of Hexosephosphoric Esters in Ossification. , 1991, The Biochemical journal.